Articles published by PanTher Therapeutics

PanTher Completes Dose Escalation Phase in Non-Metastatic Pancreatic Cancer Phase 1b Trial and Appoints Tim Clackson to the Board of Directors

May 29, 2026

From PanTher Therapeutics

Via Business Wire

PanTher Completes First Cohort in Pancreatic Cancer Phase 1b Trial Ahead of Expectations

September 10, 2025

From PanTher Therapeutics

Via Business Wire

PanTher Initiates Phase 1b Clinical Trial of Absorbable, Long-Lasting, High-Dose Chemotherapy Patch for Pancreatic Cancer

July 07, 2025

From PanTher Therapeutics

Via Business Wire

PanTher Therapeutics Receives FDA Clearance of IND Application for Phase 1b Study of PTM-101 for the Localized Treatment of Pancreatic Cancer

August 13, 2024

From PanTher Therapeutics

Via Business Wire

PanTher Therapeutics Presents Positive First-in-Human Data for PTM-101 in Pancreatic Cancer at AACR Annual Meeting

April 08, 2024

From PanTher Therapeutics

Via Business Wire

PanTher Therapeutics Announces Appointment of John Edwards as Executive Chair of the Board of Directors

April 05, 2024

From PanTher Therapeutics

Via Business Wire

PanTher Therapeutics Awarded $14.2M from CPRIT to Advance Targeted, Localized and Sustained Cancer Treatment

August 22, 2022

From PanTher Therapeutics

Via Business Wire

PanTher Therapeutics Secures Patent for Anticancer Drug-Eluting Stent

May 24, 2022

From PanTher Therapeutics

Via Business Wire

PanTher Therapeutics Doses First Two Patients in Phase 1 Trial of PTM-101 for Treatment of Pancreatic Cancer

October 06, 2021

From PanTher Therapeutics

Via Business Wire

PanTher Therapeutics Receives Ethics Approval to Initiate Phase 1 Clinical Trial of PTM-101 in Australia; Announces Appointment of Chief Medical Officer; Establishes Clinical Advisory Board

August 04, 2021

From PanTher Therapeutics

Via Business Wire

PanTher Therapeutics Closes Oversubscribed $5.4M Series A Round, Expands Board of Directors, As Company Prepares to Initiate First Clinical Trial of Novel Localized Treatment of Pancreatic Cancer

June 17, 2021

From PanTher Therapeutics

Via Business Wire

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.